iBio, Inc. — Director's Dealing 2012

Feb 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2012-02-01

Reporting Person: MUSING JULES A. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-01	Stock Option (right to buy)	$0.93	A	60000	Acquired	2022-02-01	Common Stock (60000)	Direct

Footnotes

F1: The option vests in six equal monthly installments beginning on the date of grant.